Correlation between Complement C1q A Chain (C1QA) and Macrophages in the Progression of Carotid Atherosclerosis
Abstract
Background: There is increasing evidence that macrophages are involved in the development of carotid atherosclerosis (CAS), but the specific mechanism is still unclear. We aimed to explore the key genes that play a regulatory role on macrophages in the progression of CAS.
Methods: From 2021 August to 2023 August, GEO datasets GSE100927 and GSE43292 were downloaded and the key gene modules related to CAS were identified by weighted Gene co-expression network analysis (WGCNA). Kyoto Encyclopedia of Genes and Genes (KEGG) pathway analysis was performed on the genes of the key modules to identify common gene enrichment pathways. Differential expression analysis of pathway-related genes was performed by the "limma" package of R software. Case groups were categorized into high and low expression groups based on the expression levels of key genes, and ssGSEA immune infiltration analysis was performed.
Results: The turquoise module of GSE100924 (threshold=12) and the brown module of GSE43292 (threshold=7) were obtained through WGCNA analysis. The analysis of KEGG showed that the differentially expressed genes in the turquoise and brown modules were co-enriched in the staphylococcus aureus infection signaling pathway. Differential expression analysis identified 18 common differentially expressed genes, all of which were highly expressed in the case group. C1QA is the gene of interest. According to ssGSEA analysis, the high expression group of C1QA showed a significant increase in the number of macrophages (GSE43292, P=0.0011; GSE100927, P=0.025).
Conclusion: This study identified the key gene C1QA involved in regulating macrophage functional activity during the CAS process, providing new ideas for effective control of CAS.
2. Pederiva C, Capra ME, Viggiano C, et al (2021). Early Prevention of Atheroscle-rosis: Detection and Management of Hypercholesterolaemia in Children and Adolescents. Life (Basel), 11(4):345.
3. Xue Q, He N, Wang Z, et al (2021). Func-tional roles and mechanisms of gin-senosides from Panax ginseng in ather-osclerosis. J Ginseng Res, 45(1):22-31.
4. Yin QY, Zhao B, Qiu YY, et al (2019). Re-search Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway. J Cardiovasc Pharmacol, 74(5):379-388.
5. Shi S, Kong N, Feng C, et al (2019). Drug Delivery Strategies for the Treatment of Metabolic Diseases. Adv Healthc Mater, 8(12):e1801655.
6. Reklou A, Doumas M, Imprialos K, et al (2018). Reduction of Vascular Inflamma-tion, LDL-C, or Both for the Protection from Cardiovascular Events? Open Cardi-ovasc Med J, 12:29-40.
7. Rahman M, Beg S, Verma A, et al (2017). Therapeutic Applications of Liposomal Based Drug Delivery and Drug Target-ing for Immune Linked Inflammatory Maladies: A Contemporary View Point. Curr Drug Targets, 18(13):1558-1571.
8. Bruikman CS, Stoekenbroek RM, Hovingh GK, et al (2017). New Drugs for Athero-sclerosis. Can J Cardiol, 33(3):350-357.
9. Luzzatto L, Hyry HI, Schieppati A, et al (2018). Outrageous prices of orphan drugs: a call for collaboration. Lancet, 392(10149):791-794.
10. Pothineni NVK, Subramany S, Kuriakose K, et al (2017). Infections, atherosclero-sis, and coronary heart disease. Eur Heart J, 38(43):3195-3201.
11. Wang X, Luo D, Wu S (2021). Molecular Dysfunctions of Mitochondria-Associated Endoplasmic Reticulum Contacts in Atherosclerosis. Oxid Med Cell Longev, 2021:2424509.
12. Kloc M, Uosef A, Kubiak JZ, Ghobrial RM (2020). Role of Macrophages and RhoA Pathway in Atherosclerosis. Int J Mol Sci, 22(1):216.
13. Enchill Z, Lantz C, Thorp EB (2020). Select Macrophage Noncoding RNAs of In-terest in Cardiovascular Disease. J Lipid Atheroscler, 9(1):153-161.
14. Stitham J, Rodriguez-Velez A, Zhang X, et al (2020). Inflammasomes: a preclinical assessment of targeting in atherosclero-sis. Expert Opin Ther Targets, 24(9):825-844.
15. Feng X, Chen W, Ni X, et al (2021). Met-formin, Macrophage Dysfunction and Atherosclerosis. Front Immunol, 12:682853.
16. Lin P, Ji HH, Li YJ, Guo SD (2021). Macro-phage Plasticity and Atherosclerosis Therapy. Front Mol Biosci, 8:679797.
17. Tong Y, Cai L, Yang S, et al (2020). The Re-search Progress of Vascular Macrophag-es and Atherosclerosis. Oxid Med Cell Longev, 2020:7308736.
18. Chen LH, Liu JF, Lu Y, et al (2021). Com-plement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenviron-ment Remodeling in Osteosarcoma. Front Oncol, 11:642144.
19. Kim HW, Seo SM, Kim JY, et al (2021). C1qa deficiency in mice increases sus-ceptibility to mouse hepatitis virus A59 infection. J Vet Sci, 22(3):e36.
20. Wu L, Liu D, Xia M, et al (2021). Immuno-fluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immuno-globulin a nephropathy except C1q:a single-center retrospective study. BMC Nephrol, 22(1):43.
21. Zeng J, Lai C, Luo J, Li L (2023). Functional investigation and two-sample Mendelian randomization study of neuropathic pain hub genes obtained by WGCNA analysis. Front Neurosci, 17:1134330.
22. Zhao L, Lou W, Zhang Y, et al (2023). Comprehensive analysis of HOX family genes in endometrial cancer. Transl Can-cer Res, 12(12):3728-3743.
23. Li P, Hao Z, Wu J, et al (2021). Comparative Proteomic Analysis of Polarized Human THP-1 and Mouse RAW264.7 Macro-phages. Front Immunol, 12:700009.
24. Libby P, Ridker PM, Hansson GK (2011). Progress and challenges in translating the biology of atherosclerosis. Nature, 473(7347):317-25.
25. Libby P, Ridker PM, Hansson GK et al (2009). Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol, 54(23):2129-38.
26. Geovanini GR, Libby P (2018). Atheroscle-rosis and inflammation: overview and updates. Clin Sci (Lond), 132(12):1243-1252.
27. Kaperonis EA, Liapis CD, Kakisis JD, et al (2006). Inflammation and atherosclero-sis. Eur J Vasc Endovasc Surg, 31(4):386-93.
28. Baidžajevas K, Hadadi É, Lee B, et al (2020). Macrophage polarisation associ-ated with atherosclerosis differentially affects their capacity to handle lipids. Atherosclerosis, 305:10-18.
29. Khambhati J, Engels M, Allard-Ratick M, et al (2018). Immunotherapy for the pre-vention of atherosclerotic cardiovascu-lar disease: Promise and possibilities. Atherosclerosis, 276:1-9.
30. Ridker PM, Lüscher TF (2014). Anti-inflammatory therapies for cardiovascu-lar disease. Eur Heart J, 35(27):1782-91.
31. Zhang B, Horvath S (2005). A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol, 4:Article17.
32. Wang CH, Shi HH, Chen LH, et al (2019). Identification of Key lncRNAs Associ-ated With Atherosclerosis Progression Based on Public Datasets. Front Genet, 10:123.
33. Chen S, Yang D, Liu Z, et al (2020). Crucial Gene Identification in Carotid Athero-sclerosis Based on Peripheral Blood Mononuclear Cell (PBMC) Data by Weighted (Gene) Correlation Network Analysis (WGCNA). Med Sci Monit, 26:e921692.
34. Bhatia VK, Yun S, Leung V, et al (2007). Complement C1q reduces early athero-sclerosis in low-density lipoprotein re-ceptor-deficient mice. Am J Pathol, 170(1):416-26.
35. Zhao B, Wang D, Liu Y, et al (2020). Six-Gene Signature Associated with Immune Cells in the Progression of Atheroscle-rosis Discovered by Comprehensive Bi-oinformatics Analyses. Cardiovasc Ther, 2020:1230513.
| Files | ||
| Issue | Vol 53 No 7 (2024) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v53i7.16046 | |
| Keywords | ||
| Carotid atherosclerosis Bioinformatics Macrophages Key modules Differentially expressed genes | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
